Concepedia

David S. Dickens

DS

Statistics

Publications

31

Citations

1.9K

H-Index

19

Active since

1995

Affiliations

Helen DeVos Children's Hospital(Current)

City of Hope

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Emory University

David S. Dickens is an author at Helen DeVos Children's Hospital specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

1995–2025

31

Publications

31

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio et al. · Nature · 2023 · 420 citations · Full text

Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Smita Bhatia, Wendy Landier, Muyun Shangguan et al. · Journal of Clinical Oncology · 2012 · 324 citations · Full text

6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study

Wendy Landier, Lindsey Hageman, Heeyoung Kim et al. · Blood · 2014 · 198 citations · Full text

Etanercept in the treatment of macrophage activation syndrome.

S Prahalad, Kevin E. Bove, David S. Dickens et al. · PubMed · 2001 · 142 citations

, , +18

Menin Inhibition With Revumenib for <i>KMT2A</i> -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Ghayas C. Issa, Ibrahim Aldoss, Michael J. Thirman et al. · Journal of Clinical Oncology · 2024 · 136 citations · Full text

1–5 of 31